Perspective Therapeutics, Inc. (CATX)
2.17
-0.17
(-7.26%)
USD |
NYAM |
Oct 16, 16:00
2.21
+0.04
(+1.84%)
After-Hours: 20:00
Perspective Therapeutics Cash from Investing (Quarterly) : 15.02M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.02M |
| March 31, 2026 | -109.55M |
| December 31, 2025 | 28.54M |
| September 30, 2025 | 13.99M |
| June 30, 2025 | 4.264M |
| March 31, 2025 | -5.565M |
| December 31, 2024 | -138.60M |
| September 30, 2024 | -29.74M |
| June 30, 2024 | -3.295M |
| March 31, 2024 | -47.30M |
| December 31, 2023 | |
| September 30, 2023 | -0.227M |
| June 30, 2023 | -0.573M |
| March 31, 2023 | 25.26M |
| June 30, 2022 | -0.123M |
| March 31, 2022 | -0.026M |
| December 31, 2021 | -0.081M |
| September 30, 2021 | -0.054M |
| June 30, 2021 | -0.138M |
| March 31, 2021 | -0.099M |
| December 31, 2020 | -0.06M |
| September 30, 2020 | -0.113M |
| June 30, 2020 | -0.039M |
| March 31, 2020 | -0.044M |
| December 31, 2019 | -0.106M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.098M |
| June 30, 2019 | 2.239M |
| March 31, 2019 | 2.205M |
| December 31, 2018 | 2.246M |
| September 30, 2018 | -6.289M |
| June 30, 2018 | 1.201M |
| March 31, 2018 | 0.494M |
| December 31, 2017 | 0.479M |
| September 30, 2017 | -0.315M |
| June 30, 2017 | 2.045M |
| March 31, 2017 | -0.083M |
| December 31, 2016 | -0.121M |
| September 30, 2016 | -0.327M |
| June 30, 2016 | 5.653M |
| March 31, 2016 | 5.768M |
| December 31, 2015 | -0.0871M |
| September 30, 2015 | -2.577M |
| June 30, 2015 | 4.699M |
| March 31, 2015 | 0.8751M |
| December 31, 2014 | -0.1134M |
| September 30, 2014 | -4.677M |
| June 30, 2014 | -15.42M |
| March 31, 2014 | -0.0055M |
| December 31, 2013 | -0.0114M |
| September 30, 2013 | -0.0046M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.28M |
| MiMedx Group, Inc. | -0.635M |
| ABVC BioPharma, Inc. | -0.1015M |
| Enovis Corp. | -45.01M |
| Edwards Lifesciences Corp. | -193.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.65M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow | -121.38M |
| Free Cash Flow Per Share (Quarterly) | -0.289 |
| Free Cash Flow to Equity (Quarterly) | -34.60M |
| Free Cash Flow to Firm (Quarterly) | -34.80M |
| Free Cash Flow Yield | -60.00% |